Recent Events & Catalysts
Bristol Myers Squibb (BMY) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
Agreement Shiftyesterday
BMY analyst agreement shifted
BMY's Committee agreement moved from 42.90% to 50.00% (+7.10pp, 1 day(s) apart).
Score Changeyesterday
BMY committee score rose 3.5 points
BMY's Committee score moved from 54.47 to 57.92 (+3.45, 1 day(s) apart).
Conviction Change2d ago
BMY conviction changed
BMY's Committee conviction moved from moderate to contested (1 day(s) apart).
Agreement Shift2d ago
BMY analyst agreement shifted
BMY's Committee agreement moved from 60.00% to 42.90% (-17.10pp, 1 day(s) apart).
Score Change2d ago
BMY committee score fell 9.2 points
BMY's Committee score moved from 63.70 to 54.47 (-9.23, 1 day(s) apart).
Rating Change2d ago
BMY: Buy → Watch
BMY moved from Buy to Watch (1 day(s) apart).
News
Bristol Myers Squibb Isn't Nearly as Cheap as It Looks -- Here's the 1 Thing That Could Change That
Yahoo · today
BMY Q2 Deep Dive: Growth Portfolio and Pipeline Progress Drive Upgraded Outlook
Yahoo · today
Bristol Myers Squibb Q2 Earnings Call Highlights
Yahoo · today
BioNTech: The Market Is Offering A 17-Program Oncology Pipeline For Almost Free
SeekingAlpha · 1d ago
Activist Investors Shift Back to Basics: ICR Global Head of Governance Gabriel Hasson, Live at NYSE
Yahoo · 1d ago
Bristol-Myers Squibb's Catalyst Delays May Keep Stock Range-Bound, RBC Says
Yahoo · 1d ago
AbbVie Trims Full-Year Profit Outlook Due to Apogee Acquisition
Yahoo · 1d ago
RBC Capital Maintains Sector Perform on Bristol-Myers Squibb, Raises Price Target to $64
Benzinga · 1d ago
SEC Filings (90 days)
Results of operations (earnings release), Regulation FD disclosure, Financial statements and exhibits
Filed 2026-07-30 · 2d ago · Material
Submission of matters to a vote of security holders
Filed 2026-05-08 · 85d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.